NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.

Our stock screener has singled out TG THERAPEUTICS INC (NASDAQ:TGTX) as an attractive growth opportunity. NASDAQ:TGTX is demonstrating remarkable growth potential while maintaining strong financial indicators, making it a reasonably priced option. We'll explore this further.

Growth Examination for NASDAQ:TGTX

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:TGTX has received a 7 out of 10:

• TGTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.71%, which is quite impressive.
• Looking at the last year, TGTX shows a very strong growth in Revenue. The Revenue has grown by 39.51%.
• The Revenue has been growing by 335.01% on average over the past years. This is a very strong growth!
• TGTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 229.97% yearly.
• TGTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.13% yearly.

How We Gauge Valuation for NASDAQ:TGTX

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NASDAQ:TGTX has received a 5 out of 10:

• TGTX's Price/Forward Earnings ratio is rather cheap when compared to the industry. TGTX is cheaper than 93.58% of the companies in the same industry.
• TGTX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TGTX is cheaper than 94.30% of the companies in the same industry.
• 93.94% of the companies in the same industry are more expensive than TGTX, based on the Price/Free Cash Flow ratio.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• A more expensive valuation may be justified as TGTX's earnings are expected to grow with 468.36% in the coming years.

Assessing Health Metrics for NASDAQ:TGTX

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NASDAQ:TGTX has earned a 7 out of 10:

• TGTX has an Altman-Z score of 10.12. This indicates that TGTX is financially healthy and has little risk of bankruptcy at the moment.
• The Altman-Z score of TGTX (10.12) is better than 86.27% of its industry peers.
• The Debt to FCF ratio of TGTX is 1.51, which is an excellent value as it means it would take TGTX, only 1.51 years of fcf income to pay off all of its debts.
• TGTX's Debt to FCF ratio of 1.51 is amongst the best of the industry. TGTX outperforms 95.37% of its industry peers.
• Although TGTX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
• A Current Ratio of 3.58 indicates that TGTX has no problem at all paying its short term obligations.
• TGTX has a Quick Ratio of 2.83. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.

Profitability Assessment of NASDAQ:TGTX

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:TGTX scores a 5 out of 10:

• Looking at the Return On Assets, with a value of 23.84%, TGTX belongs to the top of the industry, outperforming 98.57% of the companies in the same industry.
• The Return On Equity of TGTX (53.87%) is better than 99.11% of its industry peers.
• TGTX has a better Return On Invested Capital (27.51%) than 99.47% of its industry peers.
• TGTX has a better Profit Margin (27.59%) than 98.22% of its industry peers.
• With an excellent Operating Margin value of 29.38%, TGTX belongs to the best of the industry, outperforming 98.22% of the companies in the same industry.
• TGTX has a Gross Margin of 92.76%. This is amongst the best in the industry. TGTX outperforms 94.12% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of TGTX contains the most current fundamental analsysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.